Skip to main content
Loading
Sign In
Donate
Home
Create Account
Cart
Toggle search
Toggle navigation
Keyword Search
Sign In
Archived Public Policy Statements
2009
American College of Clinical Pharmacology
®
Position Statement on Direct-to-Consumer/Patient Advertising of Genetic Testing
2007
American College of Clinical Pharmacology
®
Position Statement on the Use of Microdosing in the Drug Development Process
2005
ACCP Letter of Comment on 2005 Best Pharmaceuticals for Children Act (BPCA) (04/28/2005)
2003
A Rational Look At Progress vs. The Precautionary Principle
Epidemiology In Decision-Making How Epidemiology Can Be Properly Used in Decision-Making - Its Strengths and Limitations
How Can I Judge Good Science?
The Annapolis Accords for Cost-Benefit Analysis Principles to Judge a Cost-Benefit Analysis
The Annapolis Accords for Risk Assessment A Citizen's Guide For Risk Assessment and Risk Management, A Set Of Principles To Guide a Risk Analysis
The Use of Toxicology in Risk Assessment and Decision-Making - Its Strengths and Limitations
2002
A special supplement released by
The Journal of Clinical Pharmacology
on the clinical consequences of Marijuana use (10/21/2002)
2000
ACCP Response to Institute of Medicine Report, "To Err is Human: Building a Safer Health System"
1999
"Clinical Pharmacology: A Retrospective View of the Future"
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##